Position in ALNY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$216,713,000
-$10,864,679 QoQ
Shares Held
719,905
+4.7% QoQ
Ownership
0.538%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#36
of 784 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FEDERATED HERMES, INC. holds $2,455,215,104 across 149 Biotechnology names. ALNY ranks #1 (8.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
719,905 | $216,713,000 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,785,716 | $198,268,046 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,884 | $160,177,448 | |
| 4 | MRNA |
Moderna, Inc.
|
1,794,778 | $125,688,301 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
749,398 | $85,933,468 | |
| 6 | EYPT |
EyePoint, Inc.
|
5,681,052 | $81,239,042 | |
| 7 | ARGX |
Argenx SE
|
87,288 | $80,983,187 | |
| 8 | ZBIO |
Zenas BioPharma, Inc.
|
3,116,805 | $79,104,510 |
All Filings in ALNY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $216,713,000 | 719,905 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $227,577,679 | 687,816 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $249,749,251 | 628,063 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $250,847,424 | 550,104 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $105,601,636 | 323,842 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $71,331,992 | 264,173 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $58,731,257 | 249,591 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $46,458,891 | 168,923 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $22,503,744 | 92,608 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $22,193,922 | 148,504 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $26,250,158 | 137,141 | Shares | Defined | 2024-01-31 | |
| 2023-06-30 | $771,156 | 4,060 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $9,275,815 | 46,305 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $11,195,453 | 47,109 | Shares | Defined | 2023-02-13 | |
| 2021-12-31 | $168,253,884 | 992,180 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $181,034,803 | 958,820 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $166,481,862 | 982,078 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $139,597,093 | 988,718 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $95,589,555 | 735,474 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $81,959,840 | 562,911 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $85,380,822 | 576,469 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $64,440,939 | 592,016 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||